Fig. 3

Patients’ survival during follow-up 1.1.2018–1.1.2021. COPD, chronic obstructive pulmonary disease; NMD, neuromuscular disease; RCWD, restrictive chest wall disease; OHS, obesity-hypoventilation syndrome; ILD, interstitial lung disease; Misc, miscellaneous